Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data

OBJECTIVE: Acute myeloid leukemia (AML) is a hematological malignancy that frequently affects elderly population. With introducing the hypomethylating agents (HMAs) in elderly AML treatment, survival rates and quality of life have improved. However, long-term management in elderly and frail patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakus, Volkan, Maral, Senem, Kaya, Egemen, Gemici, Aliihsan, Dere, Yelda, Sevindik, Omur Gokmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514083/
https://www.ncbi.nlm.nih.gov/pubmed/36276561
http://dx.doi.org/10.14744/nci.2021.42800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514083/
https://www.ncbi.nlm.nih.gov/pubmed/36276561
http://dx.doi.org/10.14744/nci.2021.42800

Ejemplares similares